Overactive bladder symptoms in women with pelvic organ prolapse before and after surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016020626387N1

Enrollment

159

Registered

2016-02-24

Start date

2013-01-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Overactive bladder. Condition 2: Pelvic organ prolapse. Other specified disorders of bladder Other female genital prolapse

Interventions

Intervention 1: Intervention group: surgery. Intervention 2: Control group: antimuscarinic drugs for 6 months.

Treatment - Surgery

Treatment - Drugs

Intervention group: surgery

Control group: antimuscarinic drugs for 6 months

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: All women with all grades of genital prolapse who can also respond to the questionnaire; Women who will be undergoing obliterative or reconstructive surgery early; Women who enrolled in the study from January 2013 to January 2014 and will be follow up for one year. Exclusion criteria: All patients who had incomplete information in their files; No satisfaction to enter the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Frequent urination. Timepoint: At the beginning of the intervention, six months after the intervention, twelve months after the intervention. Method of measurement: Pelvic floor distress inventor questionnaire (PFDI).;Urinary urgency. Timepoint: At the beginning of the intervention, six months after the intervention, twelve months after the intervention. Method of measurement: Pelvic floor distress inventor questionnaire (PFDI).;Urge incontinence. Timepoint: At the beginning of the intervention, six months after the intervention, twelve months after the intervention. Method of measurement: Pelvic floor distress inventor questionnaire (PFDI).	—

Measure

Time frame

Frequent urination. Timepoint: At the beginning of the intervention, six months after the intervention, twelve months after the intervention. Method of measurement: Pelvic floor distress inventor questionnaire (PFDI).;Urinary urgency. Timepoint: At the beginning of the intervention, six months after the intervention, twelve months after the intervention. Method of measurement: Pelvic floor distress inventor questionnaire (PFDI).;Urge incontinence. Timepoint: At the beginning of the intervention, six months after the intervention, twelve months after the intervention. Method of measurement: Pelvic floor distress inventor questionnaire (PFDI).

—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Kima Ghaed Rahmati

Moheb Yas women general hospital

kima.rahmati@gmail.com+98 21 42046

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026